Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Clinical trial NCT03855137 · COMPLETED
Trial details
- NCT number
- NCT03855137
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2022-01-20
- Enrollment
- 778
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.